EDITORIAL

CONFERENCE REPORTS

17th International AIDS Conference, 3 - 8 August 2008, Mexico City

• Introduction
• Substance use and harm reduction
• Injection drug users and HIV: evidence-based review of clinical treatment considerations
• Staphylococcal infections among injection drug users
• Abacavir and heart disease: SMART study supports an abacavir-associated increased risk of cardiovascular disease
• Selected other IDU-related studies:
• Impact of current, former or no injecting drug use on ARV access and response in Swiss patients
• Success in access to ART treatment for IDUs through PLHA network and community participation, Vietnam
• Model for scaling up access to HIV treatment for IDU in China
• Scale-up of ARV access in China
• User assessment of IDU services in Uzbekistan
• Drug treatment in Russia
• High mortality of HIV-positive IDU in Vietnam
• HIV doubles mortality rate of IDU in Chennai
• Causes of mortality in IDU in Vancouver

ANTIRETROVIRALS

• Antiretrovirals calculated to extend life expectancy by 35 years but still a 10 year difference for IDU

JOURNAL REVIEWS

• An estimated 3 million injecting drug users worldwide could be HIV-positive
• Depression improves to a similar extent when using substitution therapy with either methadone or buprenorphine
• Lower rates of spontaneous HCV clearance in HIV-positive IDUs
• Global epidemiology of HIV and IDU

DRUG INTERACTIONS

• Key papers on methadone and ritonavir
• Buprenorphine/naloxone interactions with tipranavir/ritonavir

OTHER NEWS

• IHRA Harm Reduction Conference 2009

ON THE WEB

• Web resources about ARV4IDUs

PUBLICATIONS AND SERVICES FROM i-BASE

---

Top | htb | Home | Order & subscribe | Contact | Site map | Access